Trump approves South Korea's plan to build nuclear-powered submarines, raising concerns over proliferation and regional security.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Fed Chair Powell's comments on December rate cut uncertainty send markets into a mixed reaction, with Treasury yields rising and small caps falling.
Trump approves South Korea's plan to build nuclear-powered submarines, raising concerns over proliferation and regional security.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Fed Chair Powell's comments on December rate cut uncertainty send markets into a mixed reaction, with Treasury yields rising and small caps falling.